Rexahn Pharmaceuticals
Country
USA
Краткое название
Rexahn Pharmaceuticals
Headquarters
15245 Shady Grove Road, Suite 455
Members of the board
Peter Suzdak, Ph.D. — Chief Executive Officer
Rick Soni, M.B.A. — President and Chief Operating Officer
Tae Heum (Ted) Jeong, D. Mgt. — Sr. Vice President and Chief Financial Officer
Categories medicine
Neurology, Oncology
Stage of the project
Production
Disease
Parkinson disease
Ticker
RNN
Current owners
Chang H. Ahn — Chairman
Charles Beever
Peter Brandt
Kwang Soo Cheong
Si Moon Hwang
Richard Paul Kivel
David McIntosh
Assets
120.5400
Technology
Devices, Services, Technologies, Pharmaceuticals, Chemistry